NeoGenomics Reports Record Revenue of $76 Million with 17% Organic Revenue Growth in the Fourth Quarter
19 févr. 2019 07h00 HE
|
NeoGenomics, Inc.
FT. MYERS, Fla., Feb. 19, 2019 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today reported its results for the fourth quarter...
NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2018 Earnings Release for February 19, 2019
28 janv. 2019 07h00 HE
|
NeoGenomics, Inc.
FT. MYERS, Fla., Jan. 28, 2019 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it plans to release its fourth...
NeoGenomics Appoints Dr. Lawrence M. Weiss as Chief Scientific Officer
13 déc. 2018 07h00 HE
|
NeoGenomics, Inc.
FT. MYERS, Fla., Dec. 13, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today announced the appointment of Lawrence M....
NeoGenomics Announces Pricing on Secondary Offering of Common Stock by Selling Stockholder
12 déc. 2018 07h35 HE
|
NeoGenomics, Inc.
FT. MYERS, Fla., Dec. 12, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today announced the pricing of an underwritten...
NeoGenomics Announces Secondary Offering of Common Stock by Selling Stockholder
11 déc. 2018 16h10 HE
|
NeoGenomics, Inc.
FORT MYERS, Fla., Dec. 11, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today announced that GE Medical Systems...
NeoGenomics Completes Acquisition of Genoptix, Inc.
10 déc. 2018 09h10 HE
|
NeoGenomics, Inc.
FT. MYERS, Fla., Dec. 10, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it has completed the...
QIAGEN and NeoGenomics collaborate to offer cancer patients Day-One access to innovative companion diagnostics for newly approved drugs
30 nov. 2018 17h01 HE
|
NeoGenomics, Inc.
Partners discuss efforts to accelerate precision medicine solutions at ASH 2018 HILDEN, Germany and GERMANTOWN, Md. and FORT MYERS, Fla., Nov. 30, 2018 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN;...
NeoGenomics Reports 17% Revenue Growth to Record $69 Million
30 oct. 2018 07h00 HE
|
NeoGenomics, Inc.
FT. MYERS, Fla., Oct. 30, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today reported its results for the third quarter of...
NeoGenomics Signs Definitive Agreement to Acquire Genoptix
23 oct. 2018 07h00 HE
|
NeoGenomics, Inc.
FT. MYERS, Fla., Oct. 23, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it has entered into a...
NeoGenomics Schedules its Third Quarter Earnings Release for October 30, 2018
01 oct. 2018 07h00 HE
|
NeoGenomics, Inc.
FT. MYERS, Fla., Oct. 01, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it plans to release its third...